Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients

BackgroundStudies providing more evidence to guide adjuvant chemotherapy decisions in elderly colon cancer patients are expected. MethodsWe obtained data from the Surveillance, Epidemiology and End Results (SEER) database between 2004 and 2012. Kaplan-Meier survival curves were constructed to calcul...

Full description

Bibliographic Details
Main Authors: Xin Chen, Junhao Tu, Xiaolan Xu, Wen Gu, Lei Qin, Haixin Qian, Zhenyu Jia, Chuntao Ma, Yinkai Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
chemotherapy
survival
elderly
stage II/III
colon cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.874749/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.874749/full

Similar Items